日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

An indirect comparison of zanubrutinib vs acalabrutinib plus venetoclax in patients with treatment-naive CLL

一项关于泽布替尼与阿卡替尼联合维奈托克治疗初治慢性淋巴细胞白血病患者的间接比较研究

Shadman, Mazyar; Tam, Constantine S; Brander, Danielle M; Lefebure, Marcus; Yang, Keri; Xu, Sheng; Tian, Tian; Kuptsova-Clarkson, Nataliya; Williams, Rhys; Hirata, Jamie; Munir, Talha

Zanubrutinib Versus Bendamustine and Rituximab in Patients With Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Median 5-Year Follow-Up of SEQUOIA

在初治慢性淋巴细胞白血病/小淋巴细胞淋巴瘤患者中,Zanubrutinib 与 Bendamustine 和 Rituximab 的疗效比较:SEQUOIA 研究的中位 5 年随访结果

Shadman, Mazyar; Munir, Talha; Robak, Tadeusz; Brown, Jennifer R; Kahl, Brad S; Ghia, Paolo; Giannopoulos, Krzysztof; Šimkovič, Martin; Österborg, Anders; Laurenti, Luca; Walker, Patricia A; Opat, Stephen S; Ciepluch, Hanna; Greil, Richard; Hanna, Merit; Tani, Monica; Trněný, Marek; Brander, Danielle; Flinn, Ian W; Grosicki, Sebastian; Verner, Emma; Tedeschi, Alessandra; de Guibert, Sophie; Tumyan, Gayane; Laribi, Kamel; García-Marco, José A; Li, Jian-Yong; Tian, Tian; Liu, Yu; Korolkiewicz, Roman; Szeto, Andy; Tam, Constantine S; Jurczak, Wojciech

Retreatment with venetoclax and rituximab following disease progression while off therapy in patients with chronic lymphocytic leukemia

慢性淋巴细胞白血病患者停药后疾病进展,可使用维奈托克和利妥昔单抗进行再治疗

Brander, Danielle M; Roberts, Andrew W; Kipps, Thomas J; Ma, Shuo; Anderson, Mary Ann; Boyer, Michelle; Blombery, Piers; Popovic, Relja; Roser, Jordan; Liu, Zhuangzhuang; Chyla, Brenda; Seymour, John F

Genomic characterization of chronic lymphocytic leukemia in patients of African ancestry

非洲裔慢性淋巴细胞白血病患者的基因组特征分析

Bonolo de Campos, Cecilia; McCabe, Chantal E; Bruins, Laura A; O'Brien, Daniel R; Brown, Sochilt; Tschumper, Renee C; Allmer, Cristine; Zhu, Yuan Xiao; Rabe, Kari G; Parikh, Sameer A; Kay, Neil E; Yan, Huihuang; Cerhan, James R; Allan, John N; Furman, Richard R; Weinberg, J Brice; Brander, Danielle M; Jelinek, Diane F; Chesi, Marta; Slager, Susan L; Braggio, Esteban

Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL

既往未接受过针对慢性淋巴细胞白血病(CLL)的化疗免疫治疗的里氏转化患者的预后

Kittai, Adam S; Huang, Ying; Miller, Sarah; Allan, John N; Bhat, Seema A; Bond, David A; Brander, Danielle M; Byrd, John C; Chavez, Julio C; Chong, Elise; Davids, Matthew S; Danilov, Alexey V; Ding, Wei; Dowling, Mark R; Dvorak-Kornaus, Kaitlyn; Freedman, Hannah; Hampel, Paul J; Ho, Carrie; Hwang, Steven R; Islam, Prioty; Malakhov, Nikita; Matasar, Matthew; Miller, Cecelia; Omer, Zulfa; Parikh, Sameer A; Parry, Erin; Rabe, Kari G; Raess, Philipp W; Rai, Manoj; Roeker, Lindsey; Rhodes, Joanna; Rogers, Kerry A; Saha, Aditi; Schade, Jake; Scott, Hamish W; Shadman, Mazyar; Shouse, Geoffrey; Skarbnik, Alan; Spurgeon, Stephen; Stephens, Deborah M; Thompson, Meghan C; Thompson, Philip A; Wang, Yucai; Yano, Max; Woyach, Jennifer A

Back from (BTKi) holiday

(BTKi)假期结束

Brander, Danielle M; Sitlinger, Andrea

A phase 1 study of the CDK9 inhibitor voruciclib in relapsed/refractory acute myeloid leukemia and B-cell malignancies

CDK9抑制剂voruciclib治疗复发/难治性急性髓系白血病和B细胞恶性肿瘤的I期研究

Davids, Matthew S; Brander, Danielle M; Alvarado-Valero, Yesid; Diefenbach, Catherine S; Egan, Daniel N; Dinner, Shira N; Javidi-Sharifi, Nathalie; Al Malki, Monzr M; Begna, Kebede H; Bhatt, Vijaya Raj; Abedin, Sameem; Cook, Rachel J; Collins, Mary C; Roleder, Carly; Dominguez, Edward C; Rajagopalan, Prabhu; Wiley, Sandra E; Ghalie, Richard G; Danilov, Alexey V

Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL

A041202 研究的后续结果显示,伊布替尼治疗方案对老年慢性淋巴细胞白血病 (CLL) 患者持续有效。

Woyach, Jennifer A; Perez Burbano, Gabriela; Ruppert, Amy S; Miller, Cecelia; Heerema, Nyla A; Zhao, Weiqiang; Wall, Anna; Ding, Wei; Bartlett, Nancy L; Brander, Danielle M; Barr, Paul M; Rogers, Kerry A; Parikh, Sameer A; Stephens, Deborah M; Brown, Jennifer R; Lozanski, Gerard; Blachly, James; Nattam, Sreenivasa; Larson, Richard A; Erba, Harry; Litzow, Mark; Luger, Selina; Owen, Carolyn; Kuzma, Charles; Abramson, Jeremy S; Little, Richard F; Dinner, Shira; Stone, Richard M; Uy, Geoffrey; Stock, Wendy; Mandrekar, Sumithra J; Byrd, John C

Tumor mutational load is prognostic for progression to therapy among high-count monoclonal B-cell lymphocytosis

肿瘤突变负荷是高计数单克隆B细胞淋巴细胞增多症患者治疗进展的预后指标。

Kleinstern, Geffen; Boddicker, Nicholas J; O'Brien, Daniel R; Allmer, Cristine; Rabe, Kari G; Norman, Aaron D; Griffin, Rosalie; Yan, Huihuang; Ma, Tao; Call, Timothy G; Bruins, Laura; Brown, Sochilt; Bonolo de Campos, Cecilia; Hanson, Curtis A; Leis, Jose F; Ding, Wei; Vachon, Celine M; Kay, Neil E; Oakes, Christopher C; Parker, Alexander S; Brander, Danielle M; Weinberg, J Brice; Furman, Richard R; Shanafelt, Tait D; Cerhan, James R; Parikh, Sameer A; Braggio, Esteban; Slager, Susan L

Five-year follow-up of a phase 2 study of ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial therapy in CLL

一项评估伊布替尼联合氟达拉滨、环磷酰胺和利妥昔单抗作为慢性淋巴细胞白血病一线治疗方案的II期研究的五年随访结果

Ahn, Inhye E; Brander, Danielle M; Ren, Yue; Zhou, Yinglu; Tyekucheva, Svitlana; Walker, Heather A; Black, Robert; Montegaard, Josie; Alencar, Alvaro; Shune, Leyla; Omaira, Mohammad; Jacobson, Caron A; Armand, Philippe; Ng, Samuel Y; Crombie, Jennifer; Fisher, David C; LaCasce, Ann S; Arnason, Jon; Hochberg, Ephraim P; Takvorian, Ronald W; Abramson, Jeremy S; Brown, Jennifer R; Davids, Matthew S